Moneycontrol PRO

IPCA Labs: Strong margins to sustain even post-COVID opportunities

In spite of the extraordinary sales of Hydroxychloroquine in FY21, IPCA Labs expects a 9-10 per cent growth in topline for FY22

June 02, 2021 / 10:36 AM IST
IPCA Labs: Strong margins to sustain even post-COVID opportunities

Themis Medicare | CARE has upgraded long term credit rating on the company's bank facilities to B+/Stable, from B/Stable.

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

IPCA Labs’ (CMP: Rs 2,066, Market Cap: Rs 26,197 crore) quarterly performance was a disappointment on the domestic formulations side. However, post interaction with the management, weak performance in the quarter gone by appears to be an aberration and medium-term growth for domestic formulations remains closer to mid- teens. The key near-term challenge, however, is capacity constraint for APIs (active pharmaceutical ingredients). This should be suitably addressed by a mix of de-bottlenecking and greenfield projects within a year. Overall, we remain...

  • PRO Panorama

    Moneycontrol Pro Panorama | Robinhood missed the mark on a bumper listing

    Jul 30, 2021 / 04:26 PM IST

    In today’s edition of Moneycontrol Pro Panorama:  Why Robinhood stumbled, the problem with IMF forecasts, the Immunity Tracker, Tech Mahindra’s growth appeal, Tactical Pick, the Indian startup rage, China pushes back on crypto and more  

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | The East is Red Again

    Jul 31, 2021 / 10:01 AM IST

    The market carnage spread from China’s e-commerce and fintech bigwigs such as Alibaba and Tencent to edtech companies and then to the property sector

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers